Solstein Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-196
Closed -$4K 316
2022
Q2
$4K Hold
196
﹤0.01% 300
2022
Q1
$5K Hold
196
﹤0.01% 327
2021
Q4
$6K Hold
196
﹤0.01% 352
2021
Q3
$6K Hold
196
﹤0.01% 390
2021
Q2
$7K Hold
196
0.01% 355
2021
Q1
$6K Buy
+196
New +$6.03K 0.01% 327
2019
Q3
Sell
-4,650
Closed -$157K 28
2019
Q2
$157K Hold
4,650
1.01% 28
2019
Q1
$149K Buy
+4,650
New +$143K 0.84% 30

Other funds holding ELAN

Solstein Capital's ELAN Position: Q3 2022 in Review

Solstein Capital sold out of Elanco Animal Health (ELAN) in Q3 2022, closing a stake of 196 shares — an estimated $4K sold.

Solstein Capital first reported a position in ELAN in Q1 2019 and held it in 8 quarters. The position peaked at $157K in Q2 2019. 419 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

  • Solstein Capital reported no remaining Elanco Animal Health position as of Q3 2022 after selling out during the quarter.
  • Solstein Capital sold 196 Elanco Animal Health shares in Q3 2022, an estimated $4K.
  • Solstein Capital first reported a position in Elanco Animal Health in Q1 2019 and held it in 8 quarters.
  • Solstein Capital's Elanco Animal Health position peaked at $157K in Q2 2019.
  • 419 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on Solstein Capital's 13F filing for Q3 2022, filed 1 Nov 2022.